These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 25398020)
1. Further insights into long-term trends in relative survival of vulvar cancer patients: a population-based study. Akhtar-Danesh N; Elit L; Lytwyn A Int J Gynecol Cancer; 2015 Jan; 25(1):125-30. PubMed ID: 25398020 [TBL] [Abstract][Full Text] [Related]
2. Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: a population-based study. Akhtar-Danesh N; Elit L; Lytwyn A Gynecol Oncol; 2014 Aug; 134(2):314-8. PubMed ID: 24875124 [TBL] [Abstract][Full Text] [Related]
3. Trends in of late-stage squamous cell vulvar carcinomas: analysis of the surveillance, epidemiology, and end results (SEER) database. Ramanah R; Lesieur B; Ballester M; Darai E; Rouzier R Int J Gynecol Cancer; 2012 Jun; 22(5):854-9. PubMed ID: 22426405 [TBL] [Abstract][Full Text] [Related]
4. Management and outcomes for elderly women with vulvar cancer over time. Rauh-Hain JA; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Dizon DS; Schorge JO; del Carmen MG BJOG; 2014 May; 121(6):719-27; discussion 727. PubMed ID: 24621118 [TBL] [Abstract][Full Text] [Related]
5. Vulval cancer incidence, mortality and survival in England: age-related trends. Lai J; Elleray R; Nordin A; Hirschowitz L; Rous B; Gildea C; Poole J BJOG; 2014 May; 121(6):728-38; discussion 739. PubMed ID: 24148762 [TBL] [Abstract][Full Text] [Related]
6. Temporal trends in the relative survival among women with cervical cancer in Canada: a population-based study. Akhtar-Danesh N; Elit L; Lytwyn A Int J Gynecol Cancer; 2012 Sep; 22(7):1208-13. PubMed ID: 22854653 [TBL] [Abstract][Full Text] [Related]
7. Trends in the incidence of invasive and in situ vulvar carcinoma. Judson PL; Habermann EB; Baxter NN; Durham SB; Virnig BA Obstet Gynecol; 2006 May; 107(5):1018-22. PubMed ID: 16648405 [TBL] [Abstract][Full Text] [Related]
8. Vulvar carcinoma in Norway: A 50-year perspective on trends in incidence, treatment and survival. Meltzer-Gunnes CJ; Småstuen MC; Kristensen GB; Tropé CG; Lie AK; Vistad I Gynecol Oncol; 2017 Jun; 145(3):543-548. PubMed ID: 28356187 [TBL] [Abstract][Full Text] [Related]
9. Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG study. Hellman K; Holmberg E; Bjurberg M; Borgfeldt C; Dahm-Kähler P; Flöter Rådestad A; Hjerpe E; Högberg T; Marcickiewicz J; Rosenberg P; Stålberg K; Tholander B; Kjølhede P; Åvall-Lundqvist E Gynecol Oncol; 2020 Dec; 159(3):663-671. PubMed ID: 32988623 [TBL] [Abstract][Full Text] [Related]
10. Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer. Shiozaki T; Tabata T; Ma N; Yamawaki T; Motohashi T; Kondo E; Tanida K; Okugawa T; Ikeda T Int J Gynecol Cancer; 2013 Jul; 23(6):1111-7. PubMed ID: 23765204 [TBL] [Abstract][Full Text] [Related]
11. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Stroup AM; Harlan LC; Trimble EL Gynecol Oncol; 2008 Mar; 108(3):577-83. PubMed ID: 18155274 [TBL] [Abstract][Full Text] [Related]
12. Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. Schuurman MS; van den Einden LC; Massuger LF; Kiemeney LA; van der Aa MA; de Hullu JA Eur J Cancer; 2013 Dec; 49(18):3872-80. PubMed ID: 24011936 [TBL] [Abstract][Full Text] [Related]
13. Impact of partnership status on clinical outcomes of patients with vulvar squamous cell carcinoma and performance of sentinel lymph node biopsy. Alhatem A; Lambert WC; Karanfilian K; Behbahani S; Heller D Int J Gynecol Cancer; 2020 May; 30(5):583-589. PubMed ID: 32184269 [TBL] [Abstract][Full Text] [Related]
14. Surgical staging of invasive squamous cell carcinoma of the vulva. Analysis of treatment and survival. Origoni M; Dindelli M; Ferrari D; Frigerio L; Rossi M; Ferrari A Int Surg; 1996; 81(1):67-70. PubMed ID: 8803710 [TBL] [Abstract][Full Text] [Related]
16. A comparison of younger vs older women with vulvar cancer in the United States. Kumar S; Shah JP; Bryant CS; Imudia AN; Morris RT; Malone JM Am J Obstet Gynecol; 2009 May; 200(5):e52-5. PubMed ID: 19110228 [TBL] [Abstract][Full Text] [Related]
17. Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation. Landrum LM; Skaggs V; Gould N; Walker JL; McMeekin DS Gynecol Oncol; 2008 Mar; 108(3):584-90. PubMed ID: 18155755 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for recurrence and survival in primary vulvar squamous cell cancer. Ayhan A; Velipasaoglu M; Salman MC; Guven S; Gultekin M; Bayraktar O Acta Obstet Gynecol Scand; 2008; 87(11):1143-9. PubMed ID: 18949585 [TBL] [Abstract][Full Text] [Related]
19. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. Joura EA; Lösch A; Haider-Angeler MG; Breitenecker G; Leodolter S J Reprod Med; 2000 Aug; 45(8):613-5. PubMed ID: 10986677 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in invasive squamous cell carcinoma of the vulva. Frankman O; Kabulski Z; Nilsson B; Silfverswärd C Int J Gynaecol Obstet; 1991 Nov; 36(3):219-28. PubMed ID: 1685457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]